NO20031901L - Farmasöytiske preparater - Google Patents

Farmasöytiske preparater

Info

Publication number: NO20031901L
Authority: NO; Norway
Prior art keywords: macrolide; provides; pharmaceutical preparations; dimethyisosorbide; cyclosporine
Prior art date: 1994-10-26

Application number

NO20031901A

Other languages

English (en)

Other versions

NO323063B1 (no

NO20031901D0 (no

Inventor

Sylvain Cottens

Barbara Haeberlin

Richard Sedrani

Jacky Vonerscher

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-10-26

Filing date

2003-04-28

Publication date

1997-06-24

1994-10-26 Priority claimed from GB9421613A external-priority patent/GB9421613D0/en

1994-11-02 Priority claimed from GB9422084A external-priority patent/GB9422084D0/en

1994-12-15 Priority claimed from GBGB9425353.1A external-priority patent/GB9425353D0/en

1995-08-22 Priority claimed from GBGB9517133.6A external-priority patent/GB9517133D0/en

1997-06-24 Publication of NO20031901L publication Critical patent/NO20031901L/no

2003-04-28 Application filed by Novartis Ag filed Critical Novartis Ag

2003-04-28 Publication of NO20031901D0 publication Critical patent/NO20031901D0/no

2006-12-27 Publication of NO323063B1 publication Critical patent/NO323063B1/no

Links

239000000825 pharmaceutical preparation Substances 0.000 title 1
239000003120 macrolide antibiotic agent Substances 0.000 abstract 2
PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 abstract 1
108010036949 Cyclosporine Proteins 0.000 abstract 1
239000002253 acid Substances 0.000 abstract 1
239000013543 active substance Substances 0.000 abstract 1
125000000217 alkyl group Chemical group 0.000 abstract 1
239000003795 chemical substances by application Substances 0.000 abstract 1
229960001265 ciclosporin Drugs 0.000 abstract 1
239000012141 concentrate Substances 0.000 abstract 1
229930182912 cyclosporin Natural products 0.000 abstract 1
150000002148 esters Chemical class 0.000 abstract 1
239000004530 micro-emulsion Substances 0.000 abstract 1
238000007911 parenteral administration Methods 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
239000004094 surface-active agent Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Rheumatology (AREA)
Dispersion Chemistry (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Dermatology (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Oil, Petroleum & Natural Gas (AREA)
Pain & Pain Management (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Transplantation (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Cosmetics (AREA)
Colloid Chemistry (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Investigating Or Analysing Biological Materials (AREA)

NO20031901A 1994-10-26 2003-04-28 Farmasoytisk preparat og fremgangsmate for stabilisering av et makrolid mot nedbrytning i et farmasoytisk preparat. NO323063B1 (no)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
GB9421613A GB9421613D0 (en)	1994-10-26	1994-10-26	Organic compounds
GB9422084A GB9422084D0 (en)	1994-11-02	1994-11-02	Organic compounds
GBGB9425353.1A GB9425353D0 (en)	1994-12-15	1994-12-15	Organic compounds
GBGB9517133.6A GB9517133D0 (en)	1995-08-22	1995-08-22	Pharmaceutical compositions
PCT/EP1995/004187 WO1996013273A1 (en)	1994-10-26	1995-10-25	Pharmaceutical compositions

Publications (3)

Publication Number	Publication Date
NO20031901L true NO20031901L (no)	1997-06-24
NO20031901D0 NO20031901D0 (no)	2003-04-28
NO323063B1 NO323063B1 (no)	2006-12-27

Family

ID=27451224

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
NO19971898A NO323078B1 (no)	1994-10-26	1997-04-24	Mifroemulsjonsforkonsentrat og mikroemulsjonssammensetning.
NO20031901A NO323063B1 (no)	1994-10-26	2003-04-28	Farmasoytisk preparat og fremgangsmate for stabilisering av et makrolid mot nedbrytning i et farmasoytisk preparat.

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
NO19971898A NO323078B1 (no)	1994-10-26	1997-04-24	Mifroemulsjonsforkonsentrat og mikroemulsjonssammensetning.

Country Status (25)

Country	Link
EP (2)	EP0787011B1 (no)
JP (3)	JPH10509699A (no)
KR (2)	KR100518135B1 (no)
CN (3)	CN1124157C (no)
AT (1)	ATE411800T1 (no)
AU (1)	AU714360B2 (no)
BR (1)	BR9509496A (no)
CA (1)	CA2200967C (no)
CY (1)	CY2210B1 (no)
CZ (1)	CZ289838B6 (no)
DE (2)	DE69535869D1 (no)
ES (1)	ES2316150T3 (no)
FI (1)	FI119497B (no)
HU (1)	HU225535B1 (no)
IL (3)	IL115742A (no)
MY (1)	MY129435A (no)
NO (2)	NO323078B1 (no)
NZ (1)	NZ295655A (no)
PE (1)	PE52896A1 (no)
PL (1)	PL184368B1 (no)
PT (1)	PT787011E (no)
SK (2)	SK285809B6 (no)
TR (2)	TR199500299A2 (no)
TW (1)	TW308544B (no)
WO (1)	WO1996013273A1 (no)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH686761A5 (de)	1993-05-27	1996-06-28	Sandoz Ag	Galenische Formulierungen.
NZ280689A (en) *	1995-12-15	1997-08-22	Bernard Charles Sherma Sherman	Pharmaceutical composition comprising a cyclosporipharmaceutical composition comprising a cyclosporin; a tocol, tocopherol or tocotrienol; and propylen; a tocol, tocopherol or tocotrienol; and propylene carbonate or polyethylene glycol ne carbonate or polyethylene glycol
US5958876A (en) *	1996-06-19	1999-09-28	Novartis Ag	Cyclosporin-containing pharmaceutical compositions
US6316473B1 (en) *	1997-04-11	2001-11-13	Fujisawa Pharmaceutical Co., Ltd.	Two surfactant-containing medicinal composition
US6008191A (en) *	1997-09-08	1999-12-28	Panacea Biotec Limited	Pharmaceutical compositions containing cyclosporin
US6346511B1 (en)	1997-09-08	2002-02-12	Panacea Biotec Limited	Pharmaceutical composition comprising cyclosporin
US6187747B1 (en)	1997-09-08	2001-02-13	Panacea Biotech Limited	Pharmaceutical composition comprising cyclosporin
IN188719B (no) *	1997-09-08	2002-11-02	Panacea Biotec Ltd
DE69842121D1 (de)	1997-12-10	2011-03-17	Cyclosporine Therapeutics Ltd	Omega-3 fettsäure enthaltende pharmazeutische zusammensetzungen
PL342742A1 (en) *	1998-03-06	2001-07-02	Novartis Ag	Emulsion-type pre-concentrates containing cyclosporin or macrolyde
GB2380674B (en) *	1998-03-06	2003-05-28	Novartis Ag	Emulsion preconcentrates containing cyclosporin or a macrolide
ID25908A (id) *	1998-03-06	2000-11-09	Novartis Ag	Prakonsentrat-prakonsentrat emulsi yang mengandung siklosporin atau makrolida
US6979456B1 (en)	1998-04-01	2005-12-27	Jagotec Ag	Anticancer compositions
CA2331640A1 (en) *	1998-05-07	1999-11-11	Elan Corporation Plc	Solvent/cosolvent free microemulsion and emulsion preconcentrate drug delivery systems
TWI241915B (en) *	1998-05-11	2005-10-21	Ciba Sc Holding Ag	A method of preparing a pharmaceutical end formulation using a nanodispersion
TW537894B (en) *	1998-05-26	2003-06-21	Novartis Ag	A spontaneously dispersible pharmaceutical composition comprising a piperidine substance P antagonist
GB9826656D0 (en)	1998-12-03	1999-01-27	Novartis Ag	Organic compounds
SE9804192D0 (sv) *	1998-12-03	1998-12-03	Scotia Lipidteknik Ab	New formulation
NZ512599A (en)	1998-12-30	2003-10-31	Dexcel Ltd	Formulation for cyclosporin administration featuring a hydrophilic solvent and a surfactant with a HLB of less than 5
ATE283042T1 (de) *	1999-01-28	2004-12-15	Dinesh Shantilal Patel	Parenterale lösungen enthaltend propofol (2,6- diisopropylphenol) und 2.5-di-0-methyl-1.4;3.6- dianhydro-d-glucitol als lösungsmittel
GB9903547D0 (en) *	1999-02-16	1999-04-07	Novartis Ag	Organic compounds
US6267985B1 (en) *	1999-06-30	2001-07-31	Lipocine Inc.	Clear oil-containing pharmaceutical compositions
US6294192B1 (en) *	1999-02-26	2001-09-25	Lipocine, Inc.	Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
JP2002544167A (ja)	1999-05-10	2002-12-24	ノバルティスアクチエンゲゼルシャフト	有機化合物
GB9912476D0 (en)	1999-05-28	1999-07-28	Novartis Ag	Organic compounds
DE19925001A1 (de) *	1999-05-31	2000-12-07	Pharma Concepts Gmbh & Co Kg	Flüssiges Konzentrat
US8895064B2 (en)	1999-06-14	2014-11-25	Cosmo Technologies Limited	Controlled release and taste masking oral pharmaceutical composition
DE60005819T2 (de)	1999-06-14	2004-05-06	Cosmo S.P.A.	Geschmacksmaskierte orale pharmazeutische zusammensetzungen mit kontrollierter abgabe
KR100342942B1 (ko) *	1999-07-05	2002-07-02	민경윤	카르두스 마리아누스 추출물 또는 이로부터 정제된 실리빈을함유하는 경구용 마이크로에멀젼 조성물
US20070032853A1 (en)	2002-03-27	2007-02-08	Hossainy Syed F	40-O-(2-hydroxy)ethyl-rapamycin coated stent
US7919113B2 (en)	1999-12-30	2011-04-05	Yissum Research Development Company Of The Hebrew University Of Jerusalem	Dispersible concentrate lipospheres for delivery of active agents
GB0008785D0 (en)	2000-04-10	2000-05-31	Novartis Ag	Organic compounds
DE10024451A1 (de) *	2000-05-18	2001-11-29	Asta Medica Ag	Pharmazeutische Darreichungsform für Peptide, Verfahren zu deren Herstellung und Verwendung
IT1318539B1 (it) *	2000-05-26	2003-08-27	Italfarmaco Spa	Composizioni farmaceutiche a rilascio prolungato per lasomministrazione parenterale di sostanze idrofile biologicamente
SI1333851T1 (sl) *	2000-09-18	2008-02-29	Rpg Life Sciences Ltd	Sestavek, ki sam po sebi tvori emulzijo, z izboljsanimi bioabsobcijskimi in imunosupresijskimi aktivnostmi
JP2002193790A (ja) *	2000-12-27	2002-07-10	Lion Corp	水難溶性薬剤含有水中油型エマルジョン及びその製造方法
CZ307940B6 (cs)	2001-02-19	2019-09-04	Novartis Pharma Ag	40-O-(2-hydroxyethyl)rapamycin pro použití při léčení
GB0123400D0 (en)	2001-09-28	2001-11-21	Novartis Ag	Organic compounds
WO2003032949A1 (en)	2001-10-19	2003-04-24	Isotechnika Inc.	Novel cyclosporin analog microemulsion preconcentrates
CN100346785C (zh) *	2001-10-25	2007-11-07	迪内希尚蒂拉尔·帕特尔	选择性环氧化酶ⅱ抑制剂的新型制剂
US8026276B2 (en)	2002-07-30	2011-09-27	Wyeth Llc	Parenteral CCI-779 formulations containing cosolvents, an antioxidant, and a surfactant
US20050118344A1 (en)	2003-12-01	2005-06-02	Pacetti Stephen D.	Temperature controlled crimping
IL159729A0 (en) *	2004-01-06	2004-06-20	Doron I Friedman	Non-aqueous composition for oral delivery of insoluble bioactive agents
CN101185638B (zh) *	2004-10-09	2011-04-06	山西中医学院	一种微乳制剂及其制备方法
CN100381175C (zh) *	2004-10-09	2008-04-16	山西中医学院	一种微乳制剂及其制备方法
GB0504950D0 (en)	2005-03-10	2005-04-20	Novartis Ag	Organic compositions
CN1872058B (zh) *	2005-05-31	2011-03-30	华北制药集团新药研究开发有限责任公司	一种含大环内酯类化合物的药物组合物
CA2629245C (en)	2005-11-21	2016-07-12	Novartis Ag	Neuroendocrine tumor treatment
US7883855B2 (en)	2006-07-21	2011-02-08	Abbott Laboratories	Immunosuppressant drug extraction reagent for immunoassays
CN1919194A (zh) *	2006-08-17	2007-02-28	刘瑜玲	西罗莫司的液体组合物
JP4968611B2 (ja)	2006-12-29	2012-07-04	アボット・ラボラトリーズ	免疫抑制剤の改善された測定法
WO2008082984A2 (en)	2006-12-29	2008-07-10	Abbott Laboratories	Non-denaturing lysis reagent for use with capture-in-solution immunoassay
CA2672972C (en)	2006-12-29	2015-06-23	Abbott Laboratories	Diagnostic test for the detection of a molecule or drug in whole blood
US7914999B2 (en)	2006-12-29	2011-03-29	Abbott Laboratories	Non-denaturing lysis reagent
CN104042612A (zh) *	2008-11-11	2014-09-17	得克萨斯大学体系董事会	哺乳动物雷帕霉素靶蛋白的抑制
WO2011024168A2 (en)	2009-08-26	2011-03-03	Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd	Sustained release delivery systems for the prevention and treatment of head and neck cancers
US10391059B2 (en)	2009-11-11	2019-08-27	Rapamycin Holdings, Inc.	Oral rapamycin nanoparticle preparations and use
US10154964B2 (en)	2011-09-07	2018-12-18	Cosmo Technologies Limited	Controlled release and taste masking oral pharmaceutical composition
MX2014011488A (es)	2012-03-23	2015-05-11	Univ Queensland	Agente inmunomodulador y usos para el mismo.
WO2014184734A1 (en)	2013-05-14	2014-11-20	Novartis Ag	Markers associated with mtor inhibition
WO2015044854A1 (en)	2013-09-24	2015-04-02	Novartis Ag	Markers associated with mtor inhibition
CN103933546A (zh) *	2014-03-27	2014-07-23	北京科技大学	雷帕霉素与环孢素a纳米口服微乳液制备方法
JP7459458B2 (ja) *	2018-06-28	2024-04-02	ライオン株式会社	内服組成物及びその製造方法
US20250090438A1 (en) *	2022-01-24	2025-03-20	Moresco Corporation	Nanoemulsion endowed with antiseptic effect

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR1274354A (fr)	1956-03-10	1961-10-27		Agents tensio-actifs obtenus à partir de triglycérides et polyéthylène glycol
US3244592A (en)	1962-06-09	1966-04-05	Arai Tadashi	Ascomycin and process for its production
GB1380741A (en) *	1971-02-05	1975-01-15	Squibb & Sons Inc	Antibiotic compositions and their preparation
GB1322306A (en) *	1971-04-15	1973-07-04	Meiji Seika Co	Stabilized antibiotic preparation and manufacturing process therefor
ZA737247B (en)	1972-09-29	1975-04-30	Ayerst Mckenna & Harrison	Rapamycin and process of preparation
JPS59104326A (ja) *	1982-12-04	1984-06-16	Toyo Jozo Co Ltd	マクロライド抗生物質の安定な経口用製剤および安定化法
JPS60163823A (ja) *	1984-02-03	1985-08-26	Taisho Pharmaceut Co Ltd	経口投与製剤
KR0148748B1 (ko) *	1988-09-16	1998-08-17	장 크라메르, 한스 루돌프 하우스	사이클로스포린을 함유하는 약학조성물
DE10299040I2 (de)	1989-11-09	2006-08-24	Novartis Ag	Heteroatome enthaltende tricyclische Verbindungen
MY110418A (en)	1990-07-02	1998-05-30	Novartis Ag	Heteroatoms-containing tricyclic compounds.
PT98990A (pt)	1990-09-19	1992-08-31	American Home Prod	Processo para a preparacao de esteres de acidos carboxilicos de rapamicina
US5120842A (en)	1991-04-01	1992-06-09	American Home Products Corporation	Silyl ethers of rapamycin
US5100883A (en)	1991-04-08	1992-03-31	American Home Products Corporation	Fluorinated esters of rapamycin
US5118678A (en)	1991-04-17	1992-06-02	American Home Products Corporation	Carbamates of rapamycin
US5118677A (en)	1991-05-20	1992-06-02	American Home Products Corporation	Amide esters of rapamycin
GB9113872D0 (en) *	1991-06-27	1991-08-14	Sandoz Ag	Improvements in or relating to organic compounds
US5151413A (en)	1991-11-06	1992-09-29	American Home Products Corporation	Rapamycin acetals as immunosuppressant and antifungal agents
GB9125660D0 (en)	1991-12-03	1992-01-29	Smithkline Beecham Plc	Novel compound
HUT66531A (en)	1992-05-07	1994-12-28	Sandoz Ag	Heteroatoms-containing tricyclic compounds, pharmaceutical prepns contg. them and process for producing them
DE9208647U1 (de)	1992-06-27	1992-09-24	Rademacher, Antje, 4980 Bünde	Stäbchen zur Reinigung von Ohrring-Löchern
ZA935112B (en)	1992-07-17	1994-02-08	Smithkline Beecham Corp	Rapamycin derivatives
US5234140A (en)	1992-07-28	1993-08-10	S. C. Johnson & Son, Inc.	Re-useable aerosol container
US5256790A (en)	1992-08-13	1993-10-26	American Home Products Corporation	27-hydroxyrapamycin and derivatives thereof
CZ278863B6 (en) *	1992-09-07	1994-07-13	Galena	Medicinal preparations with n-methylated cyclic undecapeptides
PT589843E (pt) *	1992-09-25	2002-04-29	Novartis Ag	Composicoes farmaceuticas contendo ciclosporinas
GB9221220D0 (en)	1992-10-09	1992-11-25	Sandoz Ag	Organic componds
FR2697040B1 (fr)	1992-10-21	1994-12-30	Ind Entreprise	Elément de protection contre le bruit et son utilisation.
US5258389A (en)	1992-11-09	1993-11-02	Merck & Co., Inc.	O-aryl, O-alkyl, O-alkenyl and O-alkynylrapamycin derivatives
CH686761A5 (de) *	1993-05-27	1996-06-28	Sandoz Ag	Galenische Formulierungen.
ES2308955T5 (es) *	1993-09-28	2012-04-03	R.P. Scherer Gmbh	Fabricación de cápsulas de gelatina blanda
AU688782B2 (en) *	1993-09-30	1998-03-19	Wyeth	Rapamycin formulations for oral administration
CA2175215C (en)	1993-11-19	2008-06-03	Yat Sun Or	Semisynthetic analogs of rapamycin (macrolides) being immunomodulators

1995
- 1995-10-24 PE PE1995282786A patent/PE52896A1/es not_active Application Discontinuation
- 1995-10-24 MY MYPI95003195A patent/MY129435A/en unknown
- 1995-10-24 IL IL11574295A patent/IL115742A/xx not_active IP Right Cessation
- 1995-10-24 IL IL12954795A patent/IL129547A/xx not_active IP Right Cessation
- 1995-10-25 CN CN95195882A patent/CN1124157C/zh not_active Expired - Fee Related
- 1995-10-25 CZ CZ19971231A patent/CZ289838B6/cs not_active IP Right Cessation
- 1995-10-25 DE DE69535869T patent/DE69535869D1/de not_active Expired - Fee Related
- 1995-10-25 EP EP95937005A patent/EP0787011B1/en not_active Expired - Lifetime
- 1995-10-25 KR KR10-2004-7010131A patent/KR100518135B1/ko not_active Expired - Fee Related
- 1995-10-25 PT PT95937005T patent/PT787011E/pt unknown
- 1995-10-25 AU AU39248/95A patent/AU714360B2/en not_active Ceased
- 1995-10-25 CA CA002200967A patent/CA2200967C/en not_active Expired - Fee Related
- 1995-10-25 WO PCT/EP1995/004187 patent/WO1996013273A1/en active IP Right Grant
- 1995-10-25 ES ES95937005T patent/ES2316150T3/es not_active Expired - Lifetime
- 1995-10-25 SK SK521-97A patent/SK285809B6/sk not_active IP Right Cessation
- 1995-10-25 HU HU9701512A patent/HU225535B1/hu not_active IP Right Cessation
- 1995-10-25 JP JP8514302A patent/JPH10509699A/ja active Pending
- 1995-10-25 KR KR1019970702753A patent/KR100541198B1/ko not_active Expired - Fee Related
- 1995-10-25 NZ NZ295655A patent/NZ295655A/xx not_active IP Right Cessation
- 1995-10-25 EP EP08166971A patent/EP2039358A1/en not_active Withdrawn
- 1995-10-25 SK SK5048-2005A patent/SK286178B6/sk not_active IP Right Cessation
- 1995-10-25 CN CNA2005100712990A patent/CN1679938A/zh active Pending
- 1995-10-25 BR BR9509496A patent/BR9509496A/pt not_active Application Discontinuation
- 1995-10-25 AT AT95937005T patent/ATE411800T1/de not_active IP Right Cessation
- 1995-10-25 DE DE19581805T patent/DE19581805T1/de not_active Withdrawn
- 1995-10-26 TR TR97/00299A patent/TR199500299A2/xx unknown
- 1995-10-26 TR TR95/01321A patent/TR199501321A2/xx unknown
- 1995-11-22 TW TW084112417A patent/TW308544B/zh active
1997
- 1997-03-10 FI FI970995A patent/FI119497B/fi active IP Right Grant
- 1997-03-25 PL PL95319691A patent/PL184368B1/pl not_active IP Right Cessation
- 1997-04-24 NO NO19971898A patent/NO323078B1/no not_active IP Right Cessation
1999
- 1999-04-22 IL IL12954799A patent/IL129547A0/xx unknown
2000
- 2000-12-01 CY CY0000066A patent/CY2210B1/xx unknown
2002
- 2002-04-20 CN CN02118150A patent/CN1404833A/zh active Pending
2003
- 2003-04-28 NO NO20031901A patent/NO323063B1/no not_active IP Right Cessation
2004
- 2004-08-25 JP JP2004245057A patent/JP2004359696A/ja active Pending
2005
- 2005-05-20 JP JP2005148267A patent/JP2005247870A/ja active Pending

Also Published As

Publication number	Publication date
TR199501321A2 (tr)	1996-06-21
MX9702701A (es)	1997-10-31
BR9509496A (pt)	1997-09-30
IL115742A (en)	2000-06-01
TR199500299A2 (tr)	1997-06-23
DE69535869D1 (de)	2008-12-04
PE52896A1 (es)	1996-12-12
PL319691A1 (en)	1997-08-18
IL129547A0 (en)	2000-02-29
KR20040074104A (ko)	2004-08-21
JP2005247870A (ja)	2005-09-15
TW308544B (no)	1997-06-21
EP0787011B1 (en)	2008-10-22
WO1996013273A1 (en)	1996-05-09
NO323063B1 (no)	2006-12-27
JP2004359696A (ja)	2004-12-24
NO323078B1 (no)	2006-12-27
SK52197A3 (en)	1997-09-10
CN1161652A (zh)	1997-10-08
JPH10509699A (ja)	1998-09-22
KR970706837A (ko)	1997-12-01
CN1404833A (zh)	2003-03-26
AU3924895A (en)	1996-05-23
ATE411800T1 (de)	2008-11-15
KR100518135B1 (ko)	2005-10-04
NO971898L (no)	1997-06-24
EP2039358A1 (en)	2009-03-25
CA2200967C (en)	2007-09-25
CA2200967A1 (en)	1996-05-09
HU225535B1 (en)	2007-02-28
HUT76858A (en)	1997-12-29
FI970995A0 (fi)	1997-03-10
NO20031901D0 (no)	2003-04-28
AU714360B2 (en)	1999-12-23
PL184368B1 (pl)	2002-10-31
KR100541198B1 (ko)	2007-04-11
FI970995L (fi)	1997-04-25
MY129435A (en)	2007-04-30
NO971898D0 (no)	1997-04-24
CN1124157C (zh)	2003-10-15
NZ295655A (en)	1998-12-23
CN1679938A (zh)	2005-10-12
CZ123197A3 (en)	1997-07-16
PT787011E (pt)	2009-01-23
FI119497B (fi)	2008-12-15
CZ289838B6 (cs)	2002-04-17
IL115742A0 (en)	1996-01-19
SK285809B6 (sk)	2007-08-02
DE19581805T1 (de)	1997-10-16
IL129547A (en)	2001-01-11
CY2210B1 (en)	2002-11-08
SK286178B6 (sk)	2008-04-07
ES2316150T3 (es)	2009-04-01
EP0787011A1 (en)	1997-08-06

Publication	Publication Date	Title
NO20031901D0 (no)	2003-04-28	Farmasöytiske preparater
EP1354582A3 (en)	2004-06-09	Emulsion preconcentrates containing cyclosporin or a macrolide
ATE554750T1 (de)	2012-05-15	Hydrophobe pharmazeutische wirkstoffe enthaltende zubereitungen
FI945619A0 (fi)	1994-11-29	Syklosporiinia sisältävät nestemäiset valmisteet ja menetelmä niiden valmistamiseksi
ES2201644T3 (es)	2004-03-16	Composicion farmaceutica a base de estrogeno y de progesterona.
WO2000074661A3 (en)	2001-06-28	Solubility enhancement of drugs in transdermal drug delivery systems and methods of use
IS4675A (is)	1998-02-25	Örþeytur til að nota sem burðarefni við inngjöf virkra efna
FI960042L (fi)	1996-01-04	Farmaseuttisia valmisteita niukkaliukoisia aktiivisia aineita varten
ATE226451T1 (de)	2002-11-15	Verfahren zum lösen von pharmazeutischen wirkstoffen in wasser und in wässrige träger
WO2000020019A3 (en)	2000-06-09	A composition for the prevention and/or treatment of atherosclerosis
NL300055I1 (nl)	2001-12-01	Repamycinepreparaten voor orale toediening.
BR9809708A (pt)	2000-07-11	Composições farmacêuticas de peptìdeos tendo solubilidade baixa em meio fisiológico
CA2273272A1 (en)	1999-04-15	Immediate release drug delivery forms
ECSP951565A (es)	1997-04-16	Composiciones farmaceuticas
CY1109190T1 (el)	2014-07-02	Φαρμακευτικα σκευασματα για παρεντερικη χορηγηση τα οποια περιεχουν εποθιλονη
CA2456970A1 (en)	1993-06-23	Drug formulations for parenteral use
MX9601756A (es)	1997-07-31	Composicion liquida estable que contiene urato-oxidasa, y composicion liofilizada para su preparacion.

Legal Events

Date	Code	Title	Description
2010-05-31	MM1K	Lapsed by not paying the annual fees